51 Chromium Labeled Red Blood Cells therapy (Us Department Of Health And Human Services)

N/A

Report date: 2026/04/17 20:02:02

Base Information

Drug Name51 Chromium Labeled Red Blood Cells therapy (Us Department Of Health And Human Services)
Drug Alias Name51Cr RBC
ClassificationCell and gene therapy > Cell therapy > Somatic cell > Erythrocyte therapyRadiation-emitting products > Nuclides > Chromium > 51Cr
Mechanisms of ActionErythropoiesis stimulants
TargetsNot applicable
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A